B

Blueprint Medicines Corp

D

BPMC

USD

1.63

(1.8251%)

Market Closed

27,961.00

حجم التداول

-4.55

الربح لكل سهم

-

العائد الربحي

-26.668622

P/E

5,760,636,587.10

حجم السوق

اليوم

1.8251%

1 اسبوع

8.120%

1 شهر

-5.004%

6 اشهر

3.411%

12 اشهر

77.098%

بداية السنة

-1.484%

كل الوقت

0%

أصول ذات صلة

Title:
Blueprint Medicines Corp

Sector:

Healthcare

Industry:

Biotechnology

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا